2[2]Da Fonte A,Rossini A,Mendonca G,et al.CYPlAl,GSTMl.and GSTT1 polymorphisms and breast cancer risk in Brazilian women[J].Cancer Lett.2002,181:179-186.
二级参考文献13
1Boyapati SM,Shu XO,Gao YT,et al.Polymorphisms in CYP1A1and breast cancer carcinoma risk in a population-based case-control study of Chinese women[J].Cancer,2005,103(11):2228-2235.
2Huang CS,Chern HD,Chang KJ,et al.Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP 17,CYP1A1,and COMT:a multigenic study on cancer susceptibility[J].Cancer Res,1999,59(19):4870-4875.
3Zheng W,Me DW,Jin F,et al.Genetic polymorphism of cytochrome P450-1 B1 and risk of breast cancer[J].Cancer Epidemiol Biomarkers Prev,2000,9(2):147-150.
4Shin A,Kang D,Nishio H,et al.Estrogen receptor alpha gene polymorphisms and breast cancer risk[J].Cancer Epidemiol Biomarkers Prev,2000,9(2):147-150.
5Cai Q,Shu XO,Jin F,et al.Genetic polymorphisms in estrogen receptor alpha gene and risk of breast cancer:results from the Shanghai breast cancer study[J].Cancer Epidemiol Biomarkers Prev,2003,12(9):853-859.
6Shen Yue Ping,Li Dekun,Zhang Zibao,et al.Joint effects of the CYP1A1 Mspl,ERal Pvu Ⅱ,and ERal Xba Ⅰ polymorphisms on the risk of breast cancer:results from a population based casecontrol study in Shanghai,China[J].Cancer Epidemiol Biomarker Prev,2006,12 (5):342-347.
7Huang CS,Shen CY,Chang KJ,et al.Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan[J].Br J Cancer,1999,80:1838-1843.
5Filippini SE, Vega A. Breast cancer genes: beyond BRCA1 and BRCA2[J]. Front Biosci (Landmark Ed), 2013, 18: 1358-1372.
6Eisinger F, Sobol H, Serin D, et al. Hereditary breast cancer,circa 1750[J]. Lancet, 1998, 351(9112) : 1366.
7Figueiredo JC, Brooks JD, Conti DV, et al. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status [ J ]. Breast Cancer Res Treat, 2011, 127 (3) : 819-829.
8Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutationsde- tected in case Series unselected for family history : a combined anal- ysis of 22 studies [J]. Am J Hum Genet, 2003, 72 (5): 1117-1130.
9M Ahmed, F Lalloo, A Howell, et al. Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers[J]. Breast Canc- er Research, 2010, 12 ( suppl 1 ) : P14.
10Spearcman AD, Sweet K, Zhou XP, et al. Clinically applicable medels to characterize BRCA1 and BRCA2 variants of uncertain significance [ J ]. J Clin Oncol, 2008, 26 (33) : 5393-5400.
